Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Grows By 250.0%

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 1,400 shares, an increase of 250.0% from the November 15th total of 400 shares. Based on an average trading volume of 8,200 shares, the days-to-cover ratio is currently 0.2 days.

BioSyent Price Performance

BIOYF traded down $0.08 on Wednesday, hitting $8.05. 251 shares of the company’s stock were exchanged, compared to its average volume of 2,252. The stock has a fifty day moving average of $8.01 and a two-hundred day moving average of $7.64. BioSyent has a twelve month low of $5.93 and a twelve month high of $8.90.

BioSyent Cuts Dividend

The firm also recently declared a dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be paid a dividend of $0.0322 per share. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, November 29th.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.